Previous research has shown that vitamin D deficiency can increase the risk of multiple sclerosis (MS) — and a new study ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...

Non-drug therapy costs for people with MS in Austria can be high, averaging €136 per month, according to a study.

Multiple sclerosis destroys the insulating outer ... which is around 20 times more than what common drug store supplements contain per dose. Overall, the researchers found that disease activity ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Dr. Alberto Ascherio of Harvard and Dr. Stephen Hauser of the University of California, San Francisco (UCSF) — will share $3 ...

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, ...

New research led by a St. Michael's Hospital clinician-scientist and published in the New England Journal of Medicine ...

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of "More Stamina," a gamified mobile health (mHealth) app designed to help people with multiple sclerosis ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed.

Previous research has shown that vitamin D deficiency can increase the risk of multiple sclerosis (MS) — and a new study suggests that supplementing it in high doses could help reduce symptoms.